Skip to main content
PMC home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Sep;64(9):3571–3575. doi: 10.1128/iai.64.9.3571-3575.1996

Inducible immunity to Trichomonas vaginalis in a mouse model of vaginal infection.

M C Abraham 1, M Desjardins 1, L G Filion 1, G E Garber 1
PMCID: PMC174265  PMID: 8751901

Abstract

We studied the protective effect of subcutaneous immunization with Trichomonas vaginalis in a mouse model of vaginal infection. BALB/c mice were immunized with various doses of T. vaginalis (4.5 x 10(5), 9 x 10(6), and 1 x 10(8) organisms per ml) suspended in Freund's complete adjuvant 56 days prior to vaginal infection and were given booster injections of the same doses of T. vaginalis in Freund's incomplete adjuvant 4 weeks later. Control mice were immunized and given booster injections of phosphate-buffered saline suspended in Freund's complete and incomplete adjuvants. The mice were tail bled and vaginal washes were performed at weekly intervals for 4 weeks to determine the isolation of T. vaginalis and the serum and vaginal antibody reactivity. Mice which had been immunized and given booster immunizations had significantly fewer intravaginal infections and had increased serum and vaginal antibody responses compared with those of control mice (P < 0.01). Mice that were vaginally infected, treated with metronidazole, and then reinfected vaginally did not develop protective immunity. Subcutaneous immunization with whole T. vaginalis organisms appears to confer protection against intravaginal challenge with T. vaginalis, protection which is not achieved as a result of prior vaginal infection.

Full Text

The Full Text of this article is available as a PDF (212.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackers J. P., Lumsden W. H., Catterall R. D., Coyle R. Antitrichomonal antibody in the vaginal secretions of women infected with T. vaginalis. Br J Vener Dis. 1975 Oct;51(5):319–323. doi: 10.1136/sti.51.5.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Alderete J. F., Kasmala L. Monoclonal antibody to a major glycoprotein immunogen mediates differential complement-independent lysis of Trichomonas vaginalis. Infect Immun. 1986 Sep;53(3):697–699. doi: 10.1128/iai.53.3.697-699.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Alderete J. F., Newton E., Dennis C., Neale K. A. The vagina of women infected with Trichomonas vaginalis has numerous proteinases and antibody to trichomonad proteinases. Genitourin Med. 1991 Dec;67(6):469–474. doi: 10.1136/sti.67.6.469. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Alderete J. F., Pearlman E. Pathogenic Trichomonas vaginalis cytotoxicity to cell culture monolayers. Br J Vener Dis. 1984 Apr;60(2):99–105. doi: 10.1136/sti.60.2.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bouvet J. P., Bélec L., Pirès R., Pillot J. Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination. Infect Immun. 1994 Sep;62(9):3957–3961. doi: 10.1128/iai.62.9.3957-3961.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Brown M. T. Trichomoniasis. Practitioner. 1972 Nov;209(253):639–644. [PubMed] [Google Scholar]
  7. Catterall R. D. Trichomonal infections of the genital tract. Med Clin North Am. 1972 Sep;56(5):1203–1209. doi: 10.1016/s0025-7125(16)32345-8. [DOI] [PubMed] [Google Scholar]
  8. Chipperfield E. J., Evans B. A. The influence of local infection on immunoglobulin formation in the human endocervix. Clin Exp Immunol. 1972 Jun;11(2):219–233. [PMC free article] [PubMed] [Google Scholar]
  9. Cogne M., Brasseur P., Ballet J. J. Detection and characterization of serum antitrichomonal antibodies in urogenital trichomoniasis. J Clin Microbiol. 1985 Apr;21(4):588–592. doi: 10.1128/jcm.21.4.588-592.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cripps A. W., Dunkley M. L., Clancy R. L. Mucosal and systemic immunizations with killed Pseudomonas aeruginosa protect against acute respiratory infection in rats. Infect Immun. 1994 Apr;62(4):1427–1436. doi: 10.1128/iai.62.4.1427-1436.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Diamond L. S., Harlow D. R., Cunnick C. C. A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba. Trans R Soc Trop Med Hyg. 1978;72(4):431–432. doi: 10.1016/0035-9203(78)90144-x. [DOI] [PubMed] [Google Scholar]
  12. Garber G. E., Lemchuk-Favel L. T., Bowie W. R. Isolation of a cell-detaching factor of Trichomonas vaginalis. J Clin Microbiol. 1989 Jul;27(7):1548–1553. doi: 10.1128/jcm.27.7.1548-1553.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Garber G. E., Proctor E. M., Bowie W. R. Immunogenic proteins of Trichomonas vaginalis as demonstrated by the immunoblot technique. Infect Immun. 1986 Jan;51(1):250–253. doi: 10.1128/iai.51.1.250-253.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Garber G. E., Sibau L., Ma R., Proctor E. M., Shaw C. E., Bowie W. R. Cell culture compared with broth for detection of Trichomonas vaginalis. J Clin Microbiol. 1987 Jul;25(7):1275–1279. doi: 10.1128/jcm.25.7.1275-1279.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Goldblum R. M. The role of IgA in local immune protection. J Clin Immunol. 1990 Nov;10(6 Suppl):64S–71S. doi: 10.1007/BF00918693. [DOI] [PubMed] [Google Scholar]
  16. Heine P., McGregor J. A. Trichomonas vaginalis: a reemerging pathogen. Clin Obstet Gynecol. 1993 Mar;36(1):137–144. doi: 10.1097/00003081-199303000-00019. [DOI] [PubMed] [Google Scholar]
  17. Holbrook T. W., Boackle R. J., Vesely J., Parker B. W. Trichomonas vaginalis: alternative pathway activation of complement. Trans R Soc Trop Med Hyg. 1982;76(4):473–475. doi: 10.1016/0035-9203(82)90140-7. [DOI] [PubMed] [Google Scholar]
  18. Jarecki-Black J. C., Lushbaugh W. B., Golosov L., Glassman A. B. Trichomonas vaginalis: preliminary characterization of a sperm motility inhibiting factor. Ann Clin Lab Sci. 1988 Nov-Dec;18(6):484–489. [PubMed] [Google Scholar]
  19. Kock R. L., Beaulieu B. B., Jr, Chrystal E. J., Goldman P. A metronidazole metabolite in human urine and its risk. Science. 1981 Jan 23;211(4480):398–400. doi: 10.1126/science.7221546. [DOI] [PubMed] [Google Scholar]
  20. Krieger J. N. Urologic aspects of trichomoniasis. Invest Urol. 1981 May;18(8):411–417. [PubMed] [Google Scholar]
  21. Kulda J., Vojtechovská M., Tachezy J., Demes P., Kunzová E. Metronidazole resistance of Trichomonas vaginalis as a cause of treatment failure in trichomoniasis--A case report. Br J Vener Dis. 1982 Dec;58(6):394–399. doi: 10.1136/sti.58.6.394. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Laga M., Alary M., Nzila N., Manoka A. T., Tuliza M., Behets F., Goeman J., St Louis M., Piot P. Condom promotion, sexually transmitted diseases treatment, and declining incidence of HIV-1 infection in female Zairian sex workers. Lancet. 1994 Jul 23;344(8917):246–248. doi: 10.1016/s0140-6736(94)93005-8. [DOI] [PubMed] [Google Scholar]
  23. Laga M., Manoka A., Kivuvu M., Malele B., Tuliza M., Nzila N., Goeman J., Behets F., Batter V., Alary M. Non-ulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS. 1993 Jan;7(1):95–102. doi: 10.1097/00002030-199301000-00015. [DOI] [PubMed] [Google Scholar]
  24. Landolfo S., Martinotti M. G., Martinetto P., Forni G. Natural cell-mediated cytotoxicity against Trichomonas vaginalis in the mouse. I. Tissue, strain, age distribution, and some characteristics of the effector cells. J Immunol. 1980 Feb;124(2):508–514. [PubMed] [Google Scholar]
  25. Lisi P. J., Dondero R. S., Kwiatkoski D., Spence M. R., Rein M. F., Alderete J. F. Monoclonal-antibody-based enzyme-linked immunosorbent assay for Trichomonas vaginalis. J Clin Microbiol. 1988 Sep;26(9):1684–1686. doi: 10.1128/jcm.26.9.1684-1686.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Mason P. R., Forman L. In vitro attraction of polymorphonuclear leucocytes by Trichomonas vaginalis. J Parasitol. 1980 Dec;66(6):888–892. [PubMed] [Google Scholar]
  27. Mason P. R., Forman L. Polymorphonuclear cell chemotaxis to secretions of pathogenic and nonpathogenic Trichomonas vaginalis. J Parasitol. 1982 Jun;68(3):457–462. [PubMed] [Google Scholar]
  28. Mason P. R., Patterson B. A. Proliferative response of human lymphocytes to secretory and cellular antigens of Trichomonas vaginalis. J Parasitol. 1985 Jun;71(3):265–268. [PubMed] [Google Scholar]
  29. Mason P. R. Serodiagnosis of Trichomonas vaginalis infection by the indirect fluorescent antibody test. J Clin Pathol. 1979 Dec;32(12):1211–1215. doi: 10.1136/jcp.32.12.1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. McGrory T., Garber G. E. Mouse intravaginal infection with Trichomonas vaginalis and role of Lactobacillus acidophilus in sustaining infection. Infect Immun. 1992 Jun;60(6):2375–2379. doi: 10.1128/iai.60.6.2375-2379.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Meysick K. C., Garber G. E. Interactions between Trichomonas vaginalis and vaginal flora in a mouse model. J Parasitol. 1992 Feb;78(1):157–160. [PubMed] [Google Scholar]
  32. Rein M. F., Sullivan J. A., Mandell G. L. Trichomonacidal activity of human polymorphonuclear neutrophils: killing by disruption and fragmentation. J Infect Dis. 1980 Oct;142(4):575–585. doi: 10.1093/infdis/142.4.575. [DOI] [PubMed] [Google Scholar]
  33. Sibau L., Bebb D., Proctor E. M., Bowie W. R. Enzyme-linked immunosorbent assay for the diagnosis of trichomoniasis in women. Sex Transm Dis. 1987 Oct-Dec;14(4):216–220. doi: 10.1097/00007435-198710000-00008. [DOI] [PubMed] [Google Scholar]
  34. Street D. A., Taylor-Robinson D., Ackers J. P., Hanna N. F., McMillan A. Evaluation of an enzyme-linked immunosorbent assay for the detection of antibody to Trichomonas vaginalis in sera and vaginal secretions. Br J Vener Dis. 1982 Oct;58(5):330–333. doi: 10.1136/sti.58.5.330. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Su K. E. Antibody to Trichomonas vaginalis in human cervicovaginal secretions. Infect Immun. 1982 Sep;37(3):852–857. doi: 10.1128/iai.37.3.852-857.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Thapar M. A., Parr E. L., Parr M. B. Secretory immune responses in mouse vaginal fluid after pelvic, parenteral or vaginal immunization. Immunology. 1990 May;70(1):121–125. [PMC free article] [PubMed] [Google Scholar]
  37. Thomason J. L., Gelbart S. M. Trichomonas vaginalis. Obstet Gynecol. 1989 Sep;74(3 Pt 2):536–541. [PubMed] [Google Scholar]
  38. Wos S. M., Watt R. M. Immunoglobulin isotypes of anti-Trichomonas vaginalis antibodies in patients with vaginal trichomoniasis. J Clin Microbiol. 1986 Nov;24(5):790–795. doi: 10.1128/jcm.24.5.790-795.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Yano A., Yui K., Aosai F., Kojima S., Kawana T., Ovary Z. Immune response to Trichomonas vaginalis. IV. Immunochemical and immunobiological analyses of T. vaginalis antigen. Int Arch Allergy Appl Immunol. 1983;72(2):150–157. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES